Additionally - main market for Eugeni right now is EU/UK - commons list approval is the main game. Australian market is a drop in the ocean, and still being dragged down the political bandwagon. Realistically if commons list is end of year approval, Eugeni will be making revenue Q1 2023, and hopefully we start maximising production to meet anticipated demand.
ADO just need to demonstrate cash flows to fund the business and give SH's confidence they wont be tapped on the shoulder again. Ellume cash will be interesting to see in the reports too. Remember the quarterly's only report CASH received - not accrued, or waiting.
- Forums
- ASX - By Stock
- ADO
- Shooting the breeze on ADO
Shooting the breeze on ADO, page-1443
-
-
- There are more pages in this discussion • 4,232 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $46.90M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $23.42K | 1.233M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1142321 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 339684 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1142321 | 0.019 |
11 | 1488162 | 0.018 |
6 | 829891 | 0.017 |
5 | 1629529 | 0.016 |
7 | 1203869 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 339684 | 2 |
0.021 | 592746 | 5 |
0.022 | 505000 | 2 |
0.023 | 420000 | 2 |
0.024 | 164509 | 3 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
ADO (ASX) Chart |